CCND1 and breast cancer: In the present study we provide a mechanism by which ligand-activated AR, down-regulates estrogen-dependent MCF-7 human breast cancer cell proliferation by inhibiting the ability of E2/ERα signalling to direct transcription of the cyclin D1 gene promoter.